Sign inJoin waitlistJoin the waitlist

ME

Manuel Espinoza-Gutarra

Physician · UAB Heersink School of Medicine

Credentials: · · · · · ·

History

UAB Heersink School of Medicine
2023–Present

Hematology and Medical Oncology
Indiana University School of Medicine
2019–2022
Internal Medicine
University of Texas Health Science Center at San Antonio
2016–2019
Faculty of Medicine San Fernando
2011–2015

Research

Thrombotic Events Are Unusual Toxicities of Chimeric Antigen Receptor T-Cell Therapies
International Journal of Molecular Sciences · 2023 · 21 citations
CD123-targeted therapy in acute myeloid leukemia
Expert Review of Hematology · 2021 · First of 4 authors · 14 citations
Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee
Review · Journal for ImmunoTherapy of Cancer · 2025 · 11 citations

OJ
Omer Jamy
11 papers · 1 as a fellow
Ravi Bhatia
8 papers
Razan Mohty
7 papers · 7 as a fellow
Anthony Sung
6 papers
Kimo Bachiashvili
6 papers
Pankit Vachhani
6 papers
Sravanti Rangaraju
6 papers
Betty Hamilton
5 papers
Catherine Lee
4 papers
Vanessa Kennedy
4 papers
Anurekha Hall
3 papers
FP
Fabiana Perna
3 papers · 3 as a resident

Clinical trials

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
Site PI · Recruiting · Phase 2, Phase 3
Moleculin Biotech, Inc.
2025–2030
Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies
Sub-investigator · Recruiting · Phase 1
University of Alabama at Birmingham
2025–2027
Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant
Sub-investigator · Recruiting · Phase 2
University of Alabama at Birmingham
2025–2027
Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
Sub-investigator · Recruiting · Phase 2
University of Alabama at Birmingham
2025–2028